Successful treatment with enasidenib, bortezomib, and dexamethasone for the synchronous occurrence of IDH2-positive acute myeloid leukemia and multiple myeloma
Published in Annals of Hematology
Contact Us To Get Started!
Work with us – your premier oncology partner – to optimize cancer care for patients